Alliance of Community Health Plans
For immediate release March 10, 2016
The Alliance of Community Health Plans (ACHP) commends the Centers for Medicare and Medicaid Services (CMS) for issuing a thoughtful set of proposals to reform Medicare Part B payment for prescription drugs. ACHP and our member plans are addressing the high cost of prescription drugs, and we support Medicare testing a multi-pronged approach that addresses reimbursement, pricing, benefit design and evidence-based decision tools. Through the 5-year test and collaboration with all stakeholders, CMS can help forge a consensus on the most effective means of reaching our shared goal: getting the right medicines to the right patients at the right price.
“While the strategies proposed by CMS are important and promising, ACHP believes that the major responsibility for unsustainable drug costs remains with the pharmaceutical manufacturers,” says President and CEO Ceci Connolly. “The industry needs to be transparent about its research and development, marketing, advertising and other costs in getting a drug to market and setting prices that reasonably reflect the true costs.”
CMS has put constructive ideas on the table. ACHP looks forward to working with CMS and others to address the critical issues of utilization and pricing of prescription drugs.
The Alliance of Community Health Plans (ACHP) is a national leadership organization bringing together innovative health plans and provider groups that are among America’s best at delivering affordable, high-quality coverage and care. ACHP’s member health plans provide coverage and care for more than 18 million Americans. These 22 organizations focus on improving the health of the communities they serve and are on the leading edge of innovations in affordability and quality of care, including primary care redesign, payment reforms, accountable health care delivery and use of information technology. To learn more about ACHP, go to www.achp.org.